Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

10 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/10/3309602/0/en/cullinan-therapeutics-shares-new-clinical-data-across-its-portfolio-of-t-cell-engager-programs-targeting-cd19-and-bcma-in-autoimmune-diseases.html

06 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/06/3307681/0/en/cullinan-therapeutics-presents-initial-clinical-data-for-cln-978-a-cd19xcd3-t-cell-engager-at-the-eular-2026-congress.html

26 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/26/3300949/0/en/cullinan-therapeutics-to-host-immunology-day-to-showcase-promising-initial-clinical-data-in-autoimmune-diseases-for-cln-978-a-cd19-t-cell-engager-and-velinotamig-a-bcma-t-cell-enga.html

19 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/19/3297322/0/en/cullinan-therapeutics-receives-fda-orphan-drug-designation-for-cln-049-a-novel-flt3xcd3-t-cell-engager-in-relapsed-refractory-acute-myeloid-leukemia.html

18 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/18/3297050/0/en/cullinan-therapeutics-to-present-initial-clinical-data-for-cln-978-in-treatment-refractory-rheumatoid-arthritis-and-systemic-lupus-erythematosus-at-eular-2026-congress.html

28 Apr 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-04-28/us-food-and-drug-administration-accepts-new-drug-application-for-zipalertinib-for-the-treatment-of
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE